IsosakuranetinCAS# 480-43-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 480-43-3 | SDF | Download SDF |
PubChem ID | 160481 | Appearance | White powder |
Formula | C16H14O5 | M.Wt | 286.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | Citrifoliol; 5,7-Dihydroxy 4'-methoxyflavanone; 4'-Methylnaringenin; Naringenin 4'-methyl ether; Ponciretin | ||
Solubility | DMSO : 125 mg/mL (436.64 mM; Need ultrasonic and warming) | ||
Chemical Name | (2S)-5,7-dihydroxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one | ||
SMILES | COC1=CC=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O | ||
Standard InChIKey | HMUJXQRRKBLVOO-AWEZNQCLSA-N | ||
Standard InChI | InChI=1S/C16H14O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Isosakuranetin is a plant exudate with known cytotoxic and fungicide properties, it may act on wheat root segments as an inhibitor of K+ permeation. Isosakuranetin is a TRPM3 blocker, significantly reduces the sensitivity of mice to noxious heat and PregS-induced chemical pain; it induced- inhibition of ERK1/2 and PI3K/AKT signaling pathways activate MITF and subsequent expression of Tyr, TRP1, and TRP2. |
Targets | ERK | PI3K | Akt | JNK | PKA | GSK-3 | Calcium Channel | Potassium Channel | Tyrosinase | TRPM3 | TRP1 | TRP2 |
In vitro | The effect of isosakuranetin (5,7-dihydroxy 4′-methoxy flavanone) on potassium uptake in wheat root segments.[Reference: WebLink]Phytochemistry, 1997, 46(2):245-8.Isosakuranetin (ISK; 5,7-dihydroxy 4′-methoxy flavanone) is a plant exudate with known cytotoxic and fungicide properties.
|
In vivo | Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.[Pubmed: 24006495]Mol Pharmacol. 2013 Nov;84(5):736-50.Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable nonselective cation channel that is expressed in a subset of dorsal root (DRG) and trigeminal ganglia sensory neurons. TRPM3 can be activated by the neurosteroid pregnenolone sulfate (PregS) and heat. TRPM3⁻/⁻ mice display an impaired sensation of noxious heat and thermal hyperalgesia. We have previously shown that TRPM3 is blocked by the citrus fruit flavanones hesperetin, naringenin, and eriodictyol as well as by ononetin, a deoxybenzoin from Ononis spinosa.
|
Cell Research | Isosakuranetin, a 4'-O-methylated flavonoid, stimulates melanogenesis in B16BL6 murine melanoma cells.[Pubmed: 26524968 ]Life Sci. 2015 Dec 15;143:43-9.The beneficial effects of 4'-O-methylated flavonoids on induction of melanogenesis are well established. Here, we report the effect of Isosakuranetin (Iso) on melanogenesis in B16BL6 melanoma cells and an analysis of the signaling pathways involved in this activity.
|
Isosakuranetin Dilution Calculator
Isosakuranetin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4928 mL | 17.4642 mL | 34.9284 mL | 69.8568 mL | 87.321 mL |
5 mM | 0.6986 mL | 3.4928 mL | 6.9857 mL | 13.9714 mL | 17.4642 mL |
10 mM | 0.3493 mL | 1.7464 mL | 3.4928 mL | 6.9857 mL | 8.7321 mL |
50 mM | 0.0699 mL | 0.3493 mL | 0.6986 mL | 1.3971 mL | 1.7464 mL |
100 mM | 0.0349 mL | 0.1746 mL | 0.3493 mL | 0.6986 mL | 0.8732 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Naringenin
Catalog No.:BCN5558
CAS No.:480-41-1
- Chrysin
Catalog No.:BCN5557
CAS No.:480-40-0
- Pinocembrin
Catalog No.:BCN5556
CAS No.:480-39-7
- Pinostrobin
Catalog No.:BCN5555
CAS No.:480-37-5
- Linarin
Catalog No.:BCN5554
CAS No.:480-36-4
- Eugenin
Catalog No.:BCN2921
CAS No.:480-34-2
- Mellein
Catalog No.:BCN4785
CAS No.:480-33-1
- Orobol
Catalog No.:BCN5553
CAS No.:480-23-9
- Aromadendrin
Catalog No.:BCN5552
CAS No.:480-20-6
- Isorhamnetin
Catalog No.:BCN5551
CAS No.:480-19-3
- Taxifolin
Catalog No.:BCN5550
CAS No.:480-18-2
- Morin
Catalog No.:BCN1028
CAS No.:480-16-0
- Acacetin
Catalog No.:BCN5560
CAS No.:480-44-4
- Hydrangenol
Catalog No.:BCN5561
CAS No.:480-47-7
- Retrorsine
Catalog No.:BCN2119
CAS No.:480-54-6
- Lecanoric acid
Catalog No.:BCN5562
CAS No.:480-56-8
- Orsellinic acid
Catalog No.:BCN6574
CAS No.:480-64-8
- 2',4',6'-Trihydroxyacetophenone
Catalog No.:BCN3996
CAS No.:480-66-0
- Jaconine
Catalog No.:BCN2089
CAS No.:480-75-1
- Jacoline
Catalog No.:BCN2088
CAS No.:480-76-2
- Platyphylline
Catalog No.:BCN2115
CAS No.:480-78-4
- Integerrimine
Catalog No.:BCN2131
CAS No.:480-79-5
- Seneciphylline
Catalog No.:BCN5563
CAS No.:480-81-9
- Indicine
Catalog No.:BCN1995
CAS No.:480-82-0
Isosakuranetin, a 4'-O-methylated flavonoid, stimulates melanogenesis in B16BL6 murine melanoma cells.[Pubmed:26524968]
Life Sci. 2015 Dec 15;143:43-9.
AIMS: The beneficial effects of 4'-O-methylated flavonoids on induction of melanogenesis are well established. Here, we report the effect of Isosakuranetin (Iso) on melanogenesis in B16BL6 melanoma cells and an analysis of the signaling pathways involved in this activity. METHODS: B16BL6 melanoma cells were treated with several concentrations of Iso and melanin content was measured. Activation and expression of factors involved in melanogenesis were assessed via western blotting. KEY FINDINGS: Iso (15 and 30mumol/L) strongly stimulated melanogenesis in a dose-dependent manner. Iso increased tyrosinase activity and up-regulated tyrosinase (Tyr), tyrosinase related protein 1 (TRP1), and tyrosinase related protein 2 (TRP2) in a time-dependent manner. Iso decreased B16 cell proliferation at a concentration above 45mumol/L, and had no effect on cell viability as revealed by MTT and trypan blue assays. Iso up-regulated expression of microphthalmia transcription factor (MITF), with a maximum effect after 12h. H89, a specific inhibitor of PKA, showed that MITF up-regulation is mediated through PKA/CREB activation. Furthermore, Iso decreased phosphorylation of MITF at Ser73 after 24h and 48h of exposure, activating MITF and leading to up-regulation of Tyr, TRP1, and TRP2. Iso inhibited phosphorylation and activation of ERK1/2 after 12h, while no significant effects on p38 and JNK phosphorylation were observed. Iso inhibited AKT phosphorylation and led to activation of GSK3beta. SIGNIFICANCE: Iso stimulates melanogenesis in B16 melanoma cells via up-regulation of MITF. Furthermore, Iso-induced inhibition of ERK1/2 and PI3K/AKT signaling pathways activate MITF and subsequent expression of Tyr, TRP1, and TRP2.
Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo.[Pubmed:24006495]
Mol Pharmacol. 2013 Nov;84(5):736-50.
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable nonselective cation channel that is expressed in a subset of dorsal root (DRG) and trigeminal ganglia sensory neurons. TRPM3 can be activated by the neurosteroid pregnenolone sulfate (PregS) and heat. TRPM3(-)/(-) mice display an impaired sensation of noxious heat and thermal hyperalgesia. We have previously shown that TRPM3 is blocked by the citrus fruit flavanones hesperetin, naringenin, and eriodictyol as well as by ononetin, a deoxybenzoin from Ononis spinosa. To further improve the tolerability, potency, and selectivity of TRPM3 blockers, we conducted a hit optimization procedure by rescreening a focused library that was composed of chemically related compounds. Within newly identified TRPM3 blockers, Isosakuranetin and liquiritigenin displayed favorable properties with respect to their inhibitory potency and a selective mode of action. Isosakuranetin, a flavanone whose glycoside is contained in blood oranges and grapefruits, displayed an IC(5)(0) of 50 nM and is to our knowledge the most potent inhibitor of TRPM3 identified so far. Both compounds exhibited a marked specificity for TRPM3 compared with other sensory TRP channels, and blocked PregS-induced intracellular free Ca(2)(+) concentration signals and ionic currents in freshly isolated DRG neurons. Furthermore, Isosakuranetin and previously identified hesperetin significantly reduced the sensitivity of mice to noxious heat and PregS-induced chemical pain. Because the physiologic functions of TRPM3 channels are still poorly defined, the development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo.